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Abstract 
 Background: Little is known about the trajectory of quality of life (QoL) following a 
first episode of psychotic mania in bipolar disorder (BD). This 18-month longitudinal study 
investigated the trajectory of QoL, and the influence of premorbid adjustment and symptoms 
on 18-month QoL in a cohort of young people experiencing a first episode of psychotic 
mania.   
Methods: As part of an overarching clinical trial, at baseline, sixty participants 
presenting with a first episode of psychotic mania (BD Type 1 – DSM-IV) completed 
symptomatic and functional assessments in addition to the Premorbid Adjustment Scale – 
General Subscale. Symptom measures were repeated at 18-month follow up. QoL was rated 
using the Quality of Life Scale (QLS) at designated time points.  
Results: Mean QLS scores at initial measurement (8 weeks) were 61% of the 
maximum possible score, increasing significantly to 70% at 12 months, and 71.2% at 18-
month follow-up. Premorbid adjustment and 18-month depressive symptoms were 
significantly associated with QoL at 18-month follow-up.  
Limitations: Study limitations include the small sample size, inclusion of participants 
with psychotic mania only, use of measures originally designed for use with schizophrenia 
spectrum disorders, and lack of premorbid or baseline measurement of QoL.  
Conclusions: Results suggest that QoL can be maintained early in BD, and reinforce 
the importance of assertively treating depressive symptoms throughout the course of this 
disorder. The emergence of a link between premorbid adjustment and poorer QoL in this 
cohort highlights the importance of assessing facets of adjustment when planning 
psychological interventions.  
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Bipolar disorder (BD) is a complex affective disorder characterised by extreme 
fluctuations in mood states. Traditionally, BD research has focused on clinical outcomes, 
symptoms, episode frequency, and/or clinically determined syndrome recovery (Michalak et 
al., 2013; Tohen et al., 2000). However, growing recognition of the distinction between 
syndromal and functional recovery in the 1980’s and 1990’s has encouraged attention to a 
broader range of outcome variables. In particular, subjective Quality of Life (QoL) in BD has 
been the focus of a rapidly expanding literature.  The overarching aim of this study was to 
further understand QoL in BD by investigating its trajectory and determinants after a first 
episode of psychotic mania.  
QoL in BD 
A widely accepted definition of QoL comes from the World Health Organisation 
Quality of Life (WHOQOL) group: “an individual’s perception of one’s positions in life in 
relation to goals, expectations, standards and concerns in context of the culture and value 
systems in which one lives” (Harper et al., 1998, p. 551). The last two decades have seen a 
significant increase in research examining QoL in BD (Murray and Michalak, 2012).  In a 
comprehensive review, it was concluded that chronic BD generates impaired QoL compared 
to healthy populations (IsHak et al., 2012), even when individuals are clinically euthymic 
(Michalak et al., 2005; Sierra et al., 2005; Xiang et al., 2014). Domains of subjective QoL 
most impacted include vocation, education, financial functioning, and intimate and social 
relationships (Michalak et al., 2006).  
Several large-scale studies have compared QoL in BD with that of cohorts diagnosed 
with other psychiatric conditions. For example, the Netherlands Mental Health Survey and 
Incidence Study (NEMESIS) found that BD was associated with significant impairment 
across most QoL domains compared with other mood disorders, anxiety disorders, and 
substance use disorders (ten Have et al., 2002). Studies contrasting QoL in outpatient 
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unipolar and BD cohorts have generated mixed results. Although lower psychological QoL 
(Berlim et al., 2004) and general QoL (Wells and Sherbourne, 1999) have been reported in 
BD cohorts (Berlim et al., 2004), other studies describe comparable QoL amongst unipolar 
and BD patients (Atkinson and Caldwell, 1997). There are also inconsistencies in the 
literature contrasting QoL in BD and schizophrenia. Comparatively poor QoL in latter stage 
BD and schizophrenia populations has been observed during phases of active 
symptomatology (Amini and Sharifi, 2012; Saarni et al., 2010) and euthymia/remission 
(Amini and Sharifi, 2012; Brissos et al., 2008; Yen et al., 2008). In contrast, other studies 
have concluded that individuals with schizophrenia have lower QoL than those with BD, 
when in clinical remission (Chand et al., 2004; Latalova et al., 2011; Michalak et al., 2008).  
QoL in first episode BD 
Despite the diagnostic and clinical importance of a first episode of mania in BD, and 
the significance of QoL as a measure of outcome at this juncture, little research has yet been 
conducted into the pattern and determinants of QoL in first episode mania.  
Only three published studies have reported on QoL in the first episode of mania in 
BD. One investigation, completed in a service providing early intervention for psychosis, 
evaluated social and symptomatic outcomes for people experiencing first episode psychotic 
mania or non-BD psychoses (schizophrenia spectrum disorders, depression with psychosis) 
(Macmillan et al., 2007). When compared to people presenting with non-BD first episode 
psychosis, individuals with first episode psychotic mania reported superior QoL and 
functioning at 3, 6 and 12-month follow-up. In another study, people who did not recover 
functionally from a first episode of psychotic mania exhibited impaired QoL across all 
domains including interpersonal relationships, instrumental role, intrapsychic foundations and 
common object activities at 12-month follow-up (Conus et al., 2006).  
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In contrast to the literature investigating multi-episode BD cohorts, recent research on 
first episode mania suggests QoL can increase in the months after treatment and may return 
to non-clinical levels (Michalak et al., 2013). The most recent investigation of first episode 
mania found that baseline QoL scores, as measured by the Quality of Life Enjoyment and 
Satisfaction Questionnaire (Q-LES-Q; Endicott et al., 1993), approached the normal range 
(70% maximum possible score). From baseline, QoL significantly improved at the 12 and 18-
month follow-up time points, and was within ranges reported for the general population 
(Michalak et al., 2013). This finding is noteworthy, because it implies that the deterioration of 
QoL reliably found in multi-episode populations is not intrinsic to the diagnosis, but may be a 
function of illness progression, increased illness burden and/or more prolonged and complex 
treatment regimes, as suggested by the BD staging model of Berk and colleagues (Berk et al., 
2007). Equally, maintained QoL after the first episode of mania would be clinically 
important, in providing a stable foundation on which to build early intervention efforts. 
Predictors of QoL in BD  
Existing research has identified a number of predictors of QoL in BD. These include 
early onset, length of illness, lack of social support (Gutierrez-Rojas et al., 2008), impaired 
functioning, mild psychotic symptoms (Cotton et al., 2010), and the addition of one or more 
comorbidities (Cotton et al., 2010; Watson et al., 2011). The two predictor variables of 
interest in this study are premorbid adjustment and illness symptoms.  
Premorbid adjustment is defined as the degree to which an individual achieves 
appropriate expectations for their sex and age, prior to the onset of illness (Phillips, 1953). 
Individuals with poor premorbid adjustment are deemed to have failed to achieve one or more 
developmental goals before the onset of the disorder, or, reached the milestone/s later in life 
than would be expected (Rodríguez Solano and González de Chávez, 2005). Deteriorating 
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premorbid adjustment has been proposed as an indicator of developing mental illness 
(Keshavan et al., 2005). 
Evidence regarding the premorbid profile in BD is emerging. Individuals with BD 
exhibit higher rates of premorbid adjustment difficulties compared to non-clinical 
populations, but less than those with schizophrenia (Cannon et al., 1997; McClellan et al., 
2003; Paya et al., 2013). Individuals with early onset BD (onset prior to 18 years of age) 
demonstrate deterioration in academic adjustment, particularly in relation to adaptation to 
school, in childhood (Paya et al., 2013) and adolescence (McClellan et al., 2003). 
Furthermore, when compared to non-clinical samples, individuals with BD display poorer 
social adjustment (Cannon et al., 1997) and reduced social and sexual functioning (Uzelac et 
al., 2006) during adolescence. 
Perhaps counterintuitively, there is also evidence that good premorbid adjustment is 
associated with increased risk of BD. Studies have observed good to excellent premorbid peer 
relationships (Kutcher et al., 1998) and school performance in individuals that have gone on 
to develop BD (Cannon et al., 1997; Kutcher et al., 1998; MacCabe et al., 2010). 
Discrepancies in findings have been attributed to the possible existence of subgroups of BD 
with differing premorbid profiles (Paya et al., 2013).  
The course of psychiatric disorders has been found to be moderated by the 
individual’s level of premorbid adjustment (Barajas et al., 2013b; Paya et al., 2013). In adult 
onset BD (onset after 18 years of age), poor childhood or adolescent adjustment has been 
linked with insidious onset BD, substance abuse or dependence, and increased suicide 
attempts. Furthermore, poor premorbid adjustment in childhood has been correlated with 
lifetime development of rapid cycling BD (Goldberg and Ernst, 2004). The relationship 
between poor premorbid adjustment and poor prognosis may be partially explained by the 
delay of diagnosis often seen in BD (Weller et al., 1995). Given that the most common index 
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episode in BD has a depressive polarity, individuals may have already experienced 
significant functional decline prior to the defining manic episode, which may also have a 
reciprocal effect on premorbid adjustment.   
In latter stage BD populations, depressive symptoms are consistently identified as a 
predictor of QoL (Amini and Sharifi, 2012; Dias et al., 2008; Michalak et al., 2008; Namjoshi 
and Buesching, 2001; Saarni et al., 2010; Xiang et al., 2014; Zhang et al., 2006). Manic states 
are typically associated with a level of QoL impairment, but generally not as severe as the 
impairment in QoL due to BD depression (Hayhurst et al., 2006; Vojta et al., 2001; Zhang et 
al., 2006). Consistent with studies of multi-episode populations, severity of depressive 
symptoms and duration of illness emerge as predictors of QoL in first episode mania samples 
(Cotton et al., 2010; Michalak et al., 2013). To date, no published studies have directly 
examined the impact of mania on QoL in the first episode. 
The present study 
Trajectory and determinants of QoL in first episode mania have received remarkably 
little attention, given the potential clinical importance of this critical stage of the disorder. 
The aims of this study were: (i) to map the trajectory of QoL over an 18-month period in a 
sample presenting with first episode psychotic mania; and (ii) to explore correlates of QoL 18 
months after a first episode of psychotic mania. The main variable of interest was premorbid 
adjustment, with baseline and 18-month symptoms of BD also being considered. Based on 
previous literature (e.g., 4) it was predicted that QoL would improve from week 8 
measurement (end of pharmaceutical trial) to the 18-month follow-up point. In accordance 
with the first episode psychosis literature (MacBeth and Gumley, 2008; Malla and Payne, 
2005), it was hypothesised that poor premorbid adjustment would be associated with 
impaired QoL 18 months following first episode psychotic mania. Based on past research 
(Amini and Sharifi, 2012; Cotton et al., 2010; Michalak et al., 2013; Renwick et al., 2012) it 
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was also hypothesised that depressive symptoms at 18 months would be associated with 
poorer QoL 18 months following first episode psychotic mania.   
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Methods 
Design 
Data were drawn from a larger research project completed between 2001 and 2006 
within the Early Psychosis Prevention and Intervention Centre (EPPIC) at Orygen Youth 
Health Clinical Program in Melbourne, Australia. The parent project was a randomised 
controlled trial (RCT) comparing chlorpromazine and olanzapine efficacy and safety profiles 
when combined with lithium, over an 8-week period, in a cohort presenting with first episode 
psychotic mania (Conus et al., 2015). The study received ethics approval from the Melbourne 
Health Research Ethics Committee. Participants were followed for 18 months with data 
relating to this study collected at the following time points: baseline, 8 weeks (end of 
pharmacological trial), 6 months, 12 months and 18 months follow-ups. Treating psychiatrists 
were free to alter medications after the 8-week RCT, or in the event of a serious adverse 
reaction. Participants were offered Orygen’s regular suite of psychotherapeutic programs, in a 
naturalistic format.   
Participants 
Patients (N = 60) were aged between 15 and 27 years, and satisfied DSM-IV criteria 
for BD I presenting with a first manic or mixed episode with psychotic features. Mania was 
confirmed via baseline Young Mania Rating Scale (YMRS; Young, Biggs, Ziegler & Meyer, 
1978) score equal to or above 20. Exclusion criteria were: Participants with immediate risk of 
harm to self or others; use of mood-stabilisers or neuroleptic medications in the two months 
prior to admission to EPPIC; intellectual disability; organic mental disease; clinically 
significant illness; haematological or biochemical abnormalities; history of epilepsy; history 
of severe drug allergy or hypersensitivity; pregnancy or lactation; and non-fluency in English.  
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Assessment instruments 
QoL was assessed at 8 weeks, 6 months, 12 months and 18 months using the Quality 
of Life Scale (QLS). The QLS is a 21-item scale designed to assess deficit symptoms 
associated with schizophrenia (Heinrichs et al., 1984). The QLS has been used extensively in 
research involving first episode BD cohorts (Conus et al., 2010; Macmillan et al., 2007; 
McGorry et al., 1996; Pena et al., 2012), and is considered an “excellent broad spectrum 
measure of multiple outcome domains” in first episode psychosis studies (McGorry et al., 
1996, p. 316). Premorbid adjustment was assessed via the Premorbid Adjustment Scale 
(PAS), a 36-item clinician-rated scale designed to measure levels of functioning prior to the 
onset of psychosis (Cannon-Spoor et al., 1982). The Premorbid Adjustment Scale (Cannon-
Spoor et al., 1982), a frequently used measure of premorbid adjustment, determines the 
“premorbid” period to end six months prior to the onset of acute symptomatology. In order to 
maximise the available data, the focus of the current study was on the General subscale, a 9-
item component of the PAS designed to provide a global rating of psychosocial development, 
and estimates of the highest level of functioning achieved prior to illness onset. The General 
subscale has demonstrated good internal consistency in populations experiencing first episode 
psychosis (Cronbach’s α = .75) (Barajas et al., 2013a) as well as with populations 
experiencing chronic psychotic disorders (Cronbach’s α = .84) (Krauss et al., 1998).  
Depression was assessed at baseline and 18 months using the Montgomery-Åsberg 
Depression Rating Scale (MADRS), a clinician administered, 10-item multipoint scale 
designed to be sensitive to treatment effects, and overall change in depressive symptoms over 
time (Montgomery and Asberg, 1979). Excellent inter-rater reliability has been reported 
(Montgomery and Asberg, 1979). The MADRS has good discriminating power, content, 
concurrent and external validity, internal consistency, transferability and homogeneity across 
a variety of clinical samples (Carmody et al., 2006; Maier et al., 1988; Moller, 2001).  
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Mania was evaluated at baseline and 18 months using the YMRS (Young et al., 1978). 
The YMRS is an 11-item rating scale designed to assess symptoms of mania including 
elevated mood, motor activity/energy, sexual interest, sleep, irritability, speech, 
language/thought disorder, thought content, disruptive/aggressive behaviour, appearance and 
insight (Young et al., 1978). The scale demonstrates good psychometric properties (inter-rater 
reliability, concurrent validity, predictive validity) as reported by the authors of the scale 
(Young et al., 1978); and strong criterion validity in child and adolescent samples (Fristad et 
al., 1995; Youngstrom et al., 2002). 
Baseline psychotic symptoms were measured using the Brief Psychiatric Rating Scale 
- version 4 (BPRS), a 24-item clinician rated scale, designed to measure severity of 
psychopathology (ref) (Overall and Gorham, 1962). The BPRS is a valid and reliable tool for 
measuring change in psychotic and affective symptoms, with good inter-rater and retest 
reliability, and good internal consistency (Burlingame et al., 2006; van Beek et al., in press).  
The BPRS Positive Symptoms Subscale (BPRS-P) was utilised to assess positive symptoms 
associated with mania and psychosis. The BPRS-P rates suspiciousness, hallucinations, 
unusual thought content, and conceptual disorganisation. 
Functioning was assessed using the Global Assessment of Functioning (GAF) and 
Social and Occupational Functioning Assessment Scale (SOFAS) (American Psychiatric 
Association, 2000), widely used psychometrically sound measures (Hilsenroth et al., 2000). 
Procedure      
All participants with manic features entering the EPPIC program were assessed by a 
member of the research team. Patients who met inclusion criteria and who were well enough 
to provide informed consent were invited to do so at the baseline interview. In the event that 
patients were too unwell to consent, the authorised psychiatrist consented to data collection 
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on their behalf. Once the patient’s condition improved sufficiently, written informed consent 
was sought. In the event that the patient declined to participate, all collected data were 
destroyed. Data pertaining to diagnosis, symptomatology, QoL and functioning were 
collected on the same day, at designated time points over the 18-month duration on the study. 
Predictor and outcome variable data were drawn from clinical and research files, which 
explains the different N values across some 18-month variables.   
Data Analysis  
Data were analysed using the IBM® SPSS® Statistics Version 22. Preliminary 
screening procedures were undertaken to determine the suitability of the data for subsequent 
analysis.  
  Assumptions underlying the statistical procedures used to test the hypotheses (mixed-
effects model repeated measures (MMRM) analysis of variance and multiple hierarchical 
regression) were checked prior to hypothesis testing. Standardised z scores (residual value > 
3.29 or <-3.29) were calculated to identify potential univariate outliers (cases with an unusual 
value for a single variable). Mahalanobis distance (critical value χ2 with 3 df 16.27, p>.01) 
and Cook’s distance (values > 1) were used to identify potential multivariate outliers (cases 
with unusual values across a number of variables) (Tabachnick and Fidell, 2001). One 
participant recorded elevated scores on both measures and was removed from analyses. 
Inspection of residual scatterplots noted no significant violations for multivariate normality, 
linearity and homoscedasticity. There was no evidence of multicollinearity or singularity.  
 Changes in QoL over time were measured using a mixed-effects MMRM. The 
within-groups factor comprised four time points (week 8, 6 months, 12 months and 18 
months).  Post hoc analyses were also conducted to determine at which time points QoL 
differed significantly.  
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Hierarchical multiple regression analysis was used to test the hypotheses regarding 
predictive factors. In the hierarchical regression, 18-month QoL was the dependent variable. 
In the first block, 18-month depression (MADRS) was entered to control for the impact of 
cross-sectional symptoms on reporting of QoL at 18-months. Assuming that 18-month 
depressive symptoms would impact QoL, this was a methodological control to keep a tight 
focus on the QoL variable. It also allowed examination of the unique contribution of 18-
month symptoms on 18-month QoL. PAS (General) was entered into the second block in 
order to identify the unique contribution of premorbid adjustment in predicting QoL 18-
months following first episode psychotic mania. For all data analyses the significance 
threshold was set at p < 0.05, with no correction for multiple comparisons.    
Potential contamination of premorbid adjustment ratings by state variables such as 
level of functioning at the time of questionnaire completion was considered. In order to 
address this potential confounding factor, correlations between baseline SOFAS and PAS 
(General) scores were investigated. No associations between these variables were detected, 
suggesting that the PAS (General) was measuring past achievement of milestones, and was 
not contaminated by functioning at the time of baseline assessment. 
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Results 
Characteristics of the Sample 
Table 1 shows baseline demographic and clinical characteristics. The mean age of the 
sample was 21.12 (SD = 2.51) with a range of 15-27 years, and approximately two thirds 
were male. The majority of participants were born in Australia.  Demographic characteristics 
were as expected for participants in this age range: Only one participant was married and six 
had children; the vast majority had completed some secondary school education, and most 
still lived in the family home. Most participants did not have a current comorbid anxiety or 
substance use disorder at the commencement of the study. All clients recorded YMRS scores 
equal to or above 20, confirming syndromal mania at study entry. The mean MADRS score 
was consistent with subsyndromal depressive symptoms (Kearns et al., 1982). Mean GAF 
and SOFAS rating suggested the sample were experiencing some impairment in reality 
testing and/or communication, as well as major impairment in functional areas such as work, 
school or family relations (American Psychiatric Association, 2000). 
INSERT TABLE 1 HERE 
Thirty-one participants (51%) did not complete all measures at the 18-month data 
collection point. Expectation maximisation algorithms were investigated as a potential 
solution to missing data, but this method produced a large number of outliers across the 
variables and so missing data were not replaced. There were no significant differences 
between completers and non-completers on demographic and baseline clinical characteristics. 
 14 
Trajectory and Predictors of QoL in FEPM   
 
Descriptive Analyses 
Changes in QoL Over Time 
QLS scores changed significantly over time (F(3, 92.6) = 5.09, p = .003), with a trend 
towards improvement across the four time points (Figure 1). Pairwise comparisons revealed a 
significant increase in QLS scores between 8 weeks and 12 months (p = .003), and between 8 
weeks and 18 months (p = .001) (12 and 18-month QLS scores did not differ significantly).  
INSERT FIGURE 1 HERE 
Correlates of QoL at 18 Months  
Baseline symptom ratings (YMRS and MADRS) were not significantly correlated 
with QLS scores at 18-month follow-up (see Table 2). There was a strong and significant 
negative correlation between PAS (General) and QLS 18 month scores, indicating poor 
premorbid adjustment was associated with reduced QLS scores 18 months after first episode 
psychotic mania. A strong and significant negative correlation was also observed between 
MADRS 18 month and QLS 18 month scores. There was no significant relationship between 
18 month YMRS and 18 month QLS scores, as would be expected given mania had remitted 
or reduced to subsyndromal levels for most participants by 18-month follow-up.  
 
INSERT TABLE 2 HERE
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Prediction of QoL at 18 months 
      The initial regression model (not presented here) had included 18-month symptoms 
(YMRS and MADRS); however, results were uninterpretable due to suppression effects. A 
subsequent regression model including the premorbid adjustment and MADRS variables is 
presented here. Eighteen-month MADRS scores were entered into the first block of the 
regression model, and PAS (General) scores were inserted into the second block. Table 3 
displays unstandardised regression coefficients (B), standard error (SE B), standardised 
regression coefficients (β), and significance levels (p) for each variable. R square change 
adjusted (R2∆) and significance of F change (∆F) for each block are also presented. 
INSERT TABLE 3 HERE 
The overall model accounted for 76.8% (adjusted) of the variance in QLS scores F(2, 
23) = 27.03, p <.001. The model demonstrates that PAS (General) was most strongly 
associated with QLS scores 18-months following first episode psychotic mania, uniquely 
accounting for 33.7% of the variance. Eighteen-month MADRS explained 24.0% of the 
variance in QLS scores 18 months following first episode psychotic mania.  
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Discussion 
  This study examined the 18-month trajectory of QoL in a cohort of young people with 
a first episode of psychotic mania. The importance of premorbid adjustment and symptoms in 
explaining QoL 18-months following first episode psychotic mania was also explored. 
Relative to the 8-week time point, QoL increased significantly at 12 and 18 months. These 
findings align with those of a recent study examining QoL in first episode mania (Michalak et 
al., 2013), which reported that perceived QoL improved significantly at 12 and 18-month 
follow-up relative to baseline.  
This replicated finding suggests that young people at the early stage of BD have a 
significant potential for global recovery. This is consistent with the recent conceptualisation 
of a staging model of BD, where functional recovery and prognosis is likely to be better in 
early episode BD (3), when patients have not endured the potentially neurotoxic and 
psychosocial impact of multiple episodes or complex and intensive treatment regimens. The 
lived experience of individuals who experience a first episode of mania may also differ from 
those that experience multiple episodes. It has been suggested that optimism can be 
maintained in early stage BD, especially when first line treatment is successful. In contrast, as 
more episodes occur and the condition progresses, the impacts on health, functioning and 
lifestyle are compounded. This accumulation of factors may underpin the decline in QoL 
often observed in multi-episode BD (Michalak et al., 2013).  
Poor premorbid adjustment was associated with impaired QoL at 18-months as 
hypothesised. In this study, premorbid adjustment was responsible for 33.7% of the variance 
in QoL at 18-month follow-up. Historically, poor premorbid adjustment has been linked with 
increased severity of symptoms and impaired functioning in first episode psychosis (MacBeth 
and Gumley, 2008). Results from this investigation provide preliminary evidence for a nexus 
between premorbid adjustment and QoL in first episode psychotic mania. Participants with 
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superior premorbid adjustment may have more established familial, psychosocial, and 
educational/vocational foundations. It may be expected that this acts as a protective platform, 
and/or facilitates return to normal functioning following first episode psychotic mania, thus 
preserving QoL.  
As anticipated, 18-month depressive symptoms were associated with QoL 18-months 
following first episode psychotic mania. At 18 months, depression accounted for 24.0% of 
variance in self-reported QoL. This finding supports those of other studies (Cotton et al., 
2010; Michalak et al., 2013; Renwick et al., 2012), highlighting the deleterious role of 
ongoing depressive symptoms on QoL in first episode mania and psychotic disorder cohorts. 
Despite the fact that mania is the defining characteristic of this condition, depression is the 
symptom feature that most markedly impacts QoL in the 18-month period following first 
episode mania (Michalak et al., 2013). Moreover, when considered alongside the suggestion 
that BD patients with psychotic features experience more subsyndromal depressive 
symptoms (Marangell et al., 2009; Tohen et al., 1990), the need to aggressively treat 
symptoms of depression early in the disorder is reaffirmed.  
Consistent with findings from a comparable recent study (Michalak et al., 2013), we 
found QoL increases in the months following stabilisation on medication subsequent to a first 
episode of psychotic mania. This replicated finding is clinically significant, as it points to a 
window of maintained QoL which may provide clinicians with a foundation on which to 
build psychological and pharmacological interventions with potential benefits for prognosis. 
Future research should investigate the optimal form of this early intervention but we note a 
priori that retained QoL may be a double-edged sword: Retained QoL may become a barrier 
to further engagement and treatment if the individual is of the opinion that everything has 
now returned to normal, and that a positive outcome is inevitable. 
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Although psychosocial interventions for first episode mania have not been extensively 
researched (Macneil et al., 2012), there is emerging evidence suggesting such treatments can 
be useful for symptom reduction (Feeny et al., 2006; Macneil et al., 2012; McMurrich et al., 
2012; Pavuluri et al., 2004) as well as promoting functioning (Macneil et al., 2012; Pavuluri 
et al., 2004). This is particularly important in early intervention services, given psychosocial 
interventions have been found to be more effective in populations reporting less than 10 
episodes, when compared to advanced stage BD cohorts (Colom et al., 2010; Scott et al., 
2007). Recently, McMurrich and colleagues (2012) highlighted the need for growth in 
psychosocial interventions for first episode mania, as well as the necessity for rigorous 
evaluation of such programs. The results of the present study further support the need to 
generate holistic psychosocial interventions incorporating the family network, social, 
educational and employment opportunities.  
The evidence for an increase in QoL subsequent to stabilisation on medication 
encourages further examination of mechanisms underlying increasing QoL following first 
episode mania. Moreover, future research could deepen our understanding of the role of 
premorbid adjustment examining the impact of separate aspects of premorbid adjustment 
(e.g., social/academic/vocational adjustment) on QoL in BD. The benefits of such 
developments would be twofold. First, any new insight into the characterisation of specific 
domains of premorbid adjustment prior to illness onset assists in refining the 
premorbid/prodromal profile of BD, potentially helping to identify at-risk individuals. 
Second, timely assessment of premorbid adjustment, including identifying areas of deficit, 
facilitates pathways into targeted interventions designed to match relevant psychosocial 
factors (Haim et al., 2006). This notion is supported by the growing literature endorsing the 
inclusion of Individual Placement and Support (IPS) programs in early intervention services. 
Such vocational programs assist individuals with severe mental illnesses to engage in 
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educational and employment opportunities (Killackey and Allott, 2013). Outcome studies 
report that such interventions have led to successful vocational outcomes for between 83% 
(Nuechterlein et al., 2008) and 85% (Killackey et al., 2008) of first episode psychosis clients, 
further emphasising the value of commencing comprehensive and holistic treatment 
programs early in illness course.    
Findings must be viewed in the context of a number of limitations. First, the small 
sample size and relatively high attrition at 18 months (51%) impacted statistical power and 
prevented further potential predictive variables from being considered for analysis. Second, 
this study was restricted to individuals with BD I psychotic mania. Therefore, it is unclear if 
the observations relating to QoL and its associates generalise to wider first episode mania 
populations, including those with BD II. Furthermore, this sample demonstrated 
comparatively low rates of comorbid anxiety (12.1%) and to a lesser degree, substance use 
(40.7%) disorders. It has been suggested that comorbid anxiety and substance use disorders 
are common in BD, and are associated with poorer QoL (IsHak et al., 2012). Thus, the low 
comorbidity observed in this sample may also limit the generalisability of findings, and may 
partially explain the observed preservation of QoL. Third, due to the absence of information 
regarding medication and therapeutic treatments following the RCT, we could not investigate 
the extent to which treatment effects account for improvements in QoL. Fourth, some 
measures used in this study were originally designed for use in populations with 
schizophrenia spectrum disorders (e.g the QLS). Contemporary BD specific scales such as 
the Quality of Life in Bipolar Disorder scale (QoL.BD) (Michalak et al., 2010) may provide a 
more accurate insight into QoL at the various stages of BD. Finally, there was no premorbid 
or baseline measurement of QoL, precluding a pure trajectory analysis.  
Strengths of the study include a longitudinal design with a first episode cohort; use of 
standardised and validated measures, and broad inclusion criteria, allowing implications to be 
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drawn from a ’real world’ population.  Structured assessment of symptom severity at baseline 
ensured that participants clearly met criteria for having experienced a manic episode.   
Conclusions 
The possibility that QoL can improve in the 18 months following the first manic 
episode offers hope to young people, families and treatment services involved in supporting 
people in the early phase of a first episode of psychotic mania. From a treatment perspective, 
maintained QoL provides a foundation on which effective treatments can be introduced, 
potentially influencing the course of BD. Studies examining how pharmacological and 
psychotherapeutic treatments influence QoL following first episode mania would be a 
welcome addition to the literature in this burgeoning area. The significant role of premorbid 
adjustment in independently influencing QoL highlights the necessity for assessing this 
dimension, and the importance of developing targeted interventions addressing pre-existing 
deficits. Furthermore, confirmation of the association between depressive symptoms and QoL 
reaffirms the need to aggressively treat such symptoms to protect QoL.  
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Table 1 
Baseline Demographic and Clinical Characteristics 
 First episode psychotic mania clients (n=60) 
Age, years, mean (SD)  21.1 (2.5) 
Sex, male, n (% valid) 39 (65) 
Born in Australia, n (% valid) 46 (76.7) 
Marital Status, single, n (% valid) 59 (98.3) 
Children, no, n (% valid) 54 (90.0) 
Accommodation, n (% valid) 
Family home 
Renting 
Other 
 
35 (58.3) 
20 (33.3) 
5 (8.4) 
 
Education, n (% valid) 
Year 7-10 
Year 11-12 
Enrolled in/completed further study 
 
 
9 (15.5) 
18 (31.0) 
31 (53.4) 
 
Work Status, n (% valid) 
Employed 
Unemployed/home duties 
Student 
 
 
19 (32.2) 
21 (35.6) 
19 (32.2) 
 
Comorbidity, n (% valid) 
Anxiety Disorder (no) 
Substance Use Disorder (no) 
 
 
51 (87.9) 
35 (59.3) 
 
Symptoms, mean (SD) 
Depression (MADRS) 
Mania (YMRS) 
BPRS 
BPRS (P) 
 
 
11.5 (5.6) 
34.83 (6.9) 
59.8 (12.5) 
13.4 (4.4) 
 
Functioning, mean (SD) 
GAF 
SOFAS 
 
 
32.6 (12.0) 
36.6 (12.9) 
Note: MADRS = Montgomery – Åsberg Depression Scale; YMRS = Young Mania Rating Scale; BPRS = Brief Psychiatric Rating Scale; 
BPRS (P) = Brief Psychiatric Rating Scale (positive symptoms); GAF = Global Assessment of Functioning Scale; SOFAS = Social and 
Occupational Functioning Assessment Scale. 
  
 32 
Trajectory and Predictors of QoL in FEPM   
 
Eighteen month YMRS and MADRS scores were positively skewed, and logarithm transformations were applied to these variables. A 
negatively skewed distribution was observed for 18 month QLS, and reflect and square root transformations were performed. Bivariate 
correlations prior to and following transformations were compared. No significant differences in correlations were observed, and 
transformations did not impact the overall pattern of findings. Given that transformation can hinder interpretation of variables, analysis of 
raw untransformed data was preferred in order to aid with the interpretation of findings (Tabachnick and Fidell, 2001).   
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Table 2 
Pearson’s Product Moment Correlations Between Quality of Life at 18 Months and Predictor Variables 
Measure QLS 18 months MADRS baseline YMRS baseline PAS (Gen) MADRS 18 months YMRS 18 months 
QLS 18 months 
 
1.00 .08 -.17 -.74*** -.67*** .19 
MADRS baseline 
 
 1.00 .31** -.12 -.07 -.18 
YMRS baseline 
 
  1.00 .04 .16 -.15 
PAS (Gen) 
 
   1.00 .27 -.30* 
MADRS 18 months 
 
    1.00 .52*** 
YMRS 18 months 
 
     1.00 
N = 44; * p < .05 ** p < .01 *** p < .001. 
Note: QLS 18 months = Quality of Life Scale – 18-month follow-up; MADRS baseline = Montgomery – Åsberg Depression Scale baseline; YMRS baseline = Young Mania Rating Scale baseline; PAS (Gen) = Premorbid 
Adjustment Scale (General Subscale); MADRS 18 months = Montgomery – Åsberg Depression Scale – 18-month follow-up; YMRS 18 months = Young Mania Rating Scale – 18-month follow-up.  
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Table 3 
Hierarchical Regression Analysis Predicting 18-Month QLS 
 
N = 53 (pairwise deletion of missing values). 
Note: MADRS 18 months = Montgomery – Åsberg Depression Scale – 18-month follow-up; PAS (Gen) = Premorbid Adjustment Scale 
(General Subscale); QLS 18 months = Quality of Life Scale – 18-month follow-up.  
 
 
 
 
 
 
 
 
 
 
 
 
Variable      Β SE Β Β P R2∆ ∆F 
Block 1     .43 <.01 
  MADRS 18 months -.13 .03 -.67 <.01   
Block 2     .77 <.01 
  MADRS 18 months -.10 .02 .51 <.01   
  PAS (Gen) -3.44 .57 -.60 <.01   
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Figure 1. Mean ± standard error (SE) estimates derived from mixed-effects model repeated 
measures analysis of variance depicting changes in QLS scores over 18 months (N = 53).  
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